{
  "authors": [
    {
      "author": "Adelaida Lamas"
    },
    {
      "author": "Luis Máiz"
    },
    {
      "author": "Marta Ruiz de Valbuena"
    },
    {
      "author": "José Manuel González-Casbas"
    },
    {
      "author": "Lucrecia Suárez"
    }
  ],
  "doi": "10.1186/1471-2466-14-165",
  "publication_date": "2014-10-26",
  "id": "EN115666",
  "url": "https://pubmed.ncbi.nlm.nih.gov/25344209",
  "source": "BMC pulmonary medicine",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "A 20-year-old female with CF with severe recurrent PE, always related to the menstrual cycle since menarche, combined with lung function decline requiring multiple courses of intravenous antibiotics. We report the cessation of PE and recovery of pulmonary function following the insertion of a subcutaneous implant with 68 mg of etonogestrel (Implanon®, Organon Española S.A. Laboratories, Madrid, Spain)."
}